Who can use Nexviazyme(Avalglucosidase alfa)?

A description of the medical condition the drug is approved to treat.

Therapeutic Indication

NEXVIAZYME is indicated for the treatment of patients 1 year of age and older with late-onset Pompe disease, which is a genetic disorder characterized by a deficiency of the lysosomal enzyme acid alpha-glucosidase (GAA). This deficiency leads to pathological accumulation of glycogen in various tissues, primarily affecting muscle and respiratory function.